Coeptis Therapeutics Holdings Inc. Common Stock

COEP

...

COEP: Coeptis Therapeutics Holdings Inc is a biopharmaceutical company developing cell therapy platforms for patients with cancer. The company's product portfolio comprises multi-antigen CAR T technology licensed from the University of Pittsburgh (SNAP-CAR), a cell therapy technology (CD38-GEAR-NK), and an in vitro diagnostic (CD38-Diagnostic) targeting CD38-related cancers, which the company is developing with VyGen-Bio and medical researchers at the Karolinska Institutet.

Show COEP Financials

All

Government

Consumer Interest

SEC Filings

ESG/Other

Congress Trading

Recent trades of COEP by members of U.S. Congress

No Congress Trading data for this ticker

Congress Trading Dashboard

Whale Activity

Recently reported changes by institutional investors

No Whale Activity for this ticker

Institutional Holdings Dashboard

Insider Trading

Quarterly net insider trading by COEP's directors and management

Corporate Lobbying

Government lobbying spending instances

No Corporate Lobbying instances for this ticker

Corporate Lobbying Dashboard

U.S. Patents

New patents grants

No new patents for this ticker

U.S. Patents Dashboard

Government Contracts

Federal grants, loans, and purchases

No Government Contracts for this ticker

Government Contracts Dashboard

Twitter

Followers on COEP's company Twitter account

WallStreetBets

Number of mentions of COEP in WallStreetBets Daily Discussion

COEP News

Recent insights relating to COEP

CNBC Recommendations

Recent picks made for COEP stock on CNBC

Top ETF Holders

ETFs with the largest estimated holdings in COEP

Corporate Flights

Flights by private jets registered to COEP